BEYONDSPRING INC.

BYSI
Real-time Estimate Quote. Real-time Estimate  - 07/02 11:56:57 am
14.925USD +0.78%
Prev.14.8100
Open14.9800
High15.1356
Low14.6000
Volume31 910
Latest news
2d ago
6d ago
06/23
06/19
Chart BEYONDSPRING INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance18,518,521,7
Ecart / Rs.-19%-19%-31%
Spread/Supp.9,9%54%44%
Support13,69,6810,4
Financials
Sales 2020 - - -
Net income 2020 -71,9 M - -
Net Debt 2020 - - -
P/E ratio 2020 -6,04x
Yield 2020 -
Capitalization 446 M 446 M -
EV / Sales 2019
Capi. / Sales 2020 -
Nbr of Employees 61
Free-Float 36,6%
Company
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. The Company’s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination...
Sector :
Bio Therapeutic Drugs
Calendar :
2020-08-24 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 4
Average target price 43,00 $
Last Close Price 14,81 $
Spread / Highest target 211%
Spread / Average Target 190%
Spread / Lowest Target 163%